Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Matt Costa is our new Professor of Orthopaedic Trauma.

The Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS) is pleased to welcome Professor Matt Costa to the department, joining from 11 May 2015 as Professor of Orthopaedic Trauma Surgery.

Matt is an internationally recognised clinical academic in orthopaedic trauma , as well as having his own clinical practice in trauma surgery. He joins us from the Warwick Clinical Trials Unit, where until recently he was Professor of Trauma and Orthopaedics.

Matt’s research interest is in clinical and cost effectiveness of musculoskeletal interventions, as well as clinical trials and trial design.

Speaking of his appointment, Professor Costa said: “I’m very excited to be joining the team at NDORMS. Musculoskeletal trauma is a huge issue for patients, the NHS and society more broadly. There are so many areas where we can improve patient care and there is no where in the world better placed to address this need than Oxford. I can’t wait to start at NDORMS and look forward to working with the world-leading academics at the University and the world-leading surgeons at the John Radcliffe Hospital”.

Professor Andrew Carr, Head of NDORMS welcomed Professor Costa and said: "I am delighted that Professor Matt Costa is joining the department. He has an international reputation in surgical trials of trauma and will add significantly to research in this area”.

Similar stories

COVID-19 vaccines shown to reduce infection by 90% in nursing homes

A new collaborative study between the Catalan Institute of Health, the Public Health Secreatariat of Catalonia, and the Centre for Statistics in Medicine, NDORMS, at the University of Oxford have confirmed that COVID-19 vaccines greatly reduce infections, hospitalisations and mortality for up to 6 months.

The Kennedy Institute completes its roof extension

Building work at the Kennedy Institute of Rheumatology has finished, providing a new third floor that houses additional meeting and collaboration space for data science and offices for the management of clinical trials.

Unlocking the secrets of the microbiome

Jethro Johnson, Deputy Director of the Oxford Centre for Microbiome Research explains how the centre is building a research community to understand the microbiome and harness its power to promote health and prevent disease.

Into the future: watching biology unfold

As part of the University of Oxford’s mission to provide its researchers with the newest state-of-the-art optical imaging equipment and as part of a strategic partnership with the Kennedy Institute of Rheumatology (KIR), the Institute of Developmental and Regenerative Medicine (IDRM), and Carl Zeiss AG (ZEISS), ZEISS has installed a ZEISS Lattice Lightsheet 7 microscope at the KIR.

New Botnar Research Institute Director starts today

Professor Jonathan Rees begins his new role as Director of the Botnar Research Institute today, taking over from Professor Andrew Carr.

Patient and public involvement in Rheumatology research – embracing the wave of change

On launching the new OPEN ARMS PPI group in Oxford, Dr. Laura Coates explored the patient and public involvement (PPI) models of three academic centres in the UK to show how it benefits researchers, clinicians, and patients alike.